¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fatty kidney"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • diabetic kidney
    ´ç´¢ÄáÆÏ, ´ç´¢º´½ÅÀå
  • double kidney
    Áߺ¹ÄáÆÏ, Áߺ¹½ÅÀå
  • elongated kidney
    ±äÄáÆÏ, ¿¬Àå½ÅÀå
  • eclamptic kidney
    ÀÚ°£ÄáÆÏ, ÀÚ°£½ÅÀå
  • ectopic kidney
    µý°÷ÄáÆÏ, À̼Ҽº½ÅÀå
  • floating kidney
    ¶áÄáÆÏ, ºÎÀ¯½ÅÀå
  • gouty kidney
    ÅëdzÄáÆÏ, Åëdz½ÅÀå
  • hypermobile kidney
    À̵¿ÄáÆÏ, À̵¿½ÅÀå
  • hind kidney
    µÚÄáÆÏ, ÈĽÅ
  • horseshoe kidney
    ¸»±ÁÄáÆÏ, ¸¶Á¦½Å
  • kidney
    ÄáÆÏ, ½ÅÀå
  • kidney disease
    ÄáÆÏº´, ½ÅÀ庴
  • kidney donor
    ÄáÆÏÁ¦°øÀÚ, ½ÅÀå°ø¿©ÀÚ
  • kidney rest
    ÄáÆÏ¹Þħ, ½ÅÀå¹Þħ
  • kidney stone
    ÄáÆÏµ¹, ½ÅÀå°á¼®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • eclamptic kidney
    ÀÚ°£ÄáÆÏ, ÀÚ°£½ÅÀå
  • ectopic kidney
    µý°÷ÄáÆÏ, µý°÷½ÅÀå
  • elongated kidney
    ±äÄáÆÏ
  • floating kidney
    (¢¡hypermobile kidney) ¶áÄáÆÏ, À̵¿ÄáÆÏ
  • gouty kidney
    ÅëdzÄáÆÏ, Åëdz½ÅÀå
  • hind kidney
    µÚÄáÆÏ
  • horseshoe kidney
    ¸»±ÁÄáÆÏ
  • hypermobile kidney
    ¶áÄáÆÏ, À̵¿ÄáÆÏ
  • kidney
    ÄáÆÏ, ½ÅÀå
  • kidney rest
    ÄáÆÏ¹Þħ, ½ÅÀå¹Þħ
  • kidney stone
    ÄáÆÏµ¹
  • lobar kidney
    ºÐ¿±ÄáÆÏ
  • microangiopathic hemolytic kidney
    ¹Ì¼¼Ç÷°üº´¿ëÇ÷ÄáÆÏ
  • movable kidney
    (¢¡hypermobile kidney) ¶áÄáÆÏ, À̵¿ÄáÆÏ
  • myeloma kidney
    °ñ¼öÁ¾ÄáÆÏ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • ren =kidney ³ª
    ½ÅÀå(ãìíô), ÄáÆÏ.
  • ren duplicatus =double kidney ³ª
    Áߺ¹½Å(ñìÜÜãì)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pancreatogenous fatty diarrhea
    ÃéÀ强 Áö¹æ¼³»ç(¡­ò·Û¸àÜÞá).
  • polyunsaturate fatty acid
    ´Ù(Òý)ºÒÆ÷È­Áö¹æ»ê.
  • saturated fatty acid
    Æ÷È­Áö¹æ»ê(øéûùò·Û¸ß«).
  • subcutaneous fatty tissue
    ÇÇÇÏÁö¹æÁ¶Á÷.
  • total fatty acids
    ÃÑÁö¹æ»ê(õÅò·Û¸ß«).
  • unesterified fatty acid
    ºñ¿¡½ºÅ׸£È­Áö¹æ»ê(Þª¡­ûùò·Û¸ß«).
  • unesterified fatty acid
    ºñ¿¡½ºÅ׸£È­Áö¹æ»ê(Þª¡­ûùò·Û¸ß«)
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê (¡­ò·Û¸ß«).
  • acquired cystic disease of the kidney
    ÈÄõ¼º ½Å³¶Æ÷Áúȯ
  • adenocarcinoma of kidney
    ½Å¼±¾Ï
  • amyloid kidney
    ¾Æ¹Ð·ÎÀÌµå ½Å
  • arteriosclerotic kidney
    µ¿¸Æ°æÈ­¼º ½Å (¡­ãì).
  • artificial kidney
    Àΰø ½ÅÀå(ìÑÍïãìíô)
  • artificial kidney
    Àΰø½ÅÀå.
  • cadaver kidney
    »çü½Å(ÞÝô÷ãì).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AFLP acute fatty liver of pregnancy
AFM aflatoxin M; after fatty meal; American Federation of Musicians
EFA Epilepsy Foundation of America; essential fatty acid; extrafamily adoptee
EFAD essential fatty acid deficiency
FA false aneurysm; Families Anonymous; Fanconi anemia; far advanced; fatty acid; febrile antigen; femor...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FAME Fatty Acid Methyl Ester
FLHS Fatty Liver Haemorrhagic Syndrome
FAAH Fatty acid amide hydrolase
FABP Fatty acid binding protein
FAEE Fatty acid ethyl ester
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • kidney nephrotic syndrome
    ½Å ÁõÈıº
  • kidney tuberculosis
    ½Å °áÇÙ
  • medullary sponge kidney
    ¼öÁú¼º ÇØ¸é ½Å, ¼öÁú¼º ÇØ¸é»ó ½Å
  • monkey kidney cell
    ¿ø¼þÀÌ ½Å¼¼Æ÷
  • pelvic kidney
    °ñ¹Ý½Å
    ½ÅÀåÀÌ Á¤»ó À§Ä¡¿¡ ¾ø°í ¼±ÃµÀûÀ¸·Î °ñ¹ÝºÎ¿¡ ÀÖ´Â °ÍÀ» ¸»ÇÑ´Ù.
  • polycystic kidney disease
    ´Ù³¶ ½Å Áúȯ
  • ring shaped kidney
    À±»ó ½Å
  • shock kidney
    ¼îÅ©¼º ½Å ±â´É Àå¾Ö
    ¼îÅ©¿¡ ºüÁ® Ç÷¾Ð ÀúÇϰ¡ ±æ°Ô À̾îÁ® ½Å Ç÷·ù·®ÀÌ °¨¼ÒÇÏ¿© »ý±ä ±Þ¼º ½Å ºÎÀü.
  • sigmoid kidney
    ¿¡½ºÀÚ»ó ½Å
    ÇÑÂÊ ½ÅÀÚÀÇ »ó±ØÀÌ ´Ù¸¥ ÂÊ ½ÅÀåÀÇ Çϱذú À¶ÇÕµÈ º¯Çü À¶ÇÕ ½Å.
  • solitary kidney
    ´Ü½Å, ´Ü½ÅÁõ
  • transplantation of kidney
    ¸é¿ª ½Å À̽Ä
    µ¿ÀǾî=renal trans
  • trifid kidney
    »ï¿­ ½Å
  • tumors of the kidney
    ½ÅÀå Á¾¾ç
    ½ÅÀå¿¡ ¹ß»ýÇÏ´Â Á¾¾ç. ¾Ç¼ºÀÎ °ÍÀÌ ¸¹À¸¸ç, ±× ´ëºÎºÐÀº ±×¶óºñÃ÷ Á¾¾çÀ̶ó ÇÏ´Â ½Å ½ÇÁú¿¡ »ý±â´Â ¼±¾ÏÀÌ´Ù. ÀÌ ¹Û¿¡ ½Å¿ì¿¡ »ý±â´Â À¯µÎÁ¾À̳ª À¯À¯¾Æ¿¡ »ý±â´Â ºô¸§½º Á¾¾ç µîÀÌ ÀÖ´Ù. ÁÖ¿ä Áõ¼¼·Î´Â ÀϹÝÀûÀ¸·Î Ç÷´¢, Á¾·ù, ½ÅºÎ µ¿ÅëÀÇ 3°¡ÁöÀÌÁö¸¸, ¹ß¿­À̳ª ±âħ, ±× ¹Û¿¡ ¿©·¯ °¡Áö Àü½Å Áõ¼¼·Î ½ÃÀ۵Ǵ °Íµµ ¸¹´Ù. ½Å¿ì ÃÔ¿µ, ½Åµ¿¸Æ ÃÔ¿µ µîÀ¸·Î Áø´ÜÇÑ´Ù. Ä¡·á´Â °¡±ÞÀûÀ̸é Á¶±â¿¡ ¹ß°ßÇÏ¿© ½ÅÀåÀ» ÀûÃâÇÏ°í ´ÙÀ½¿¡ ¹æ»ç¼± ¿ä¹ýÀ» ¾´´Ù. ºô¸§½º Á¾¾ç¿¡´Â ¾ÇƼ³ë¸¶À̽ŠDÀÇ Ç×¾ÏÁ¦°¡ À¯È¿ÇÏ´Ù.
  • vein of kidney
    ÄáÆÏ Á¤¸Æ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
fatty acids, omega-3 A group of fatty acids, often of marine origin, which have the first unsaturated bond in the third position from the omega carbon. These fatty acids are believed to reduce serum triglycerides, prevent insulin resistance, improve lipid profile, prolong bleeding times, reduce platelet counts, and decrease platelet adhesiveness.
(12 Dec 1998)
fatty acids, unsaturated Fatty acids containing one (monounsaturated) or multiple (polyunsaturated) double bonds. They predominate in most plant-derived fats. The number and position of each double bond can be specified, as in the systematic names, or the position of the double bond closest to the methyl group (omega) terminus can be specified to denote functional subdivisions of the overall group, e.g., omega-3 fatty acids. The numbers and positions of the double bonds have been linked to effects on plasma lipid, triglyceride, and cholesterol levels.
(12 Dec 1998)
fatty acids, volatile Short-chain fatty acids of up to six carbon atoms in length. They are the major end products of microbial fermentation in the ruminant digestive tract and have also been implicated in the causation of neurological diseases in humans.
(12 Dec 1998)
fatty acid synthase complex The multienzyme complex that catalyses the formation of palmitate from acetylcoenzyme A, malonylcoenzyme A, and NADPH.
(05 Mar 2000)
fatty acid synthetase complex <enzyme> Registry number: EC 6.-
(12 Dec 1998)
fatty acid thiokinase Long chain: long-chain fatty acid-CoA ligase, medium chain: butyrate-CoA ligase.
(05 Mar 2000)
fatty acyl ethyl ester synthase <enzyme> Myocardial enzyme; esterifies free fatty acids in the absence of ATP and coenzyme a; the fatty acid ethyl ester synthase III has homology with glutathione s-transferase
Registry number: EC 2.3.1.-
Synonym: fatty acid ethyl ester synthase, fatty acid ethyl ester synthase III, faee synthase, faees-iii gene product
(26 Jun 1999)
fatty alcohol A long chain alcohol, analogous to the fatty acids, of which the fatty alcohol may be viewed as a reduction product; e.g., octadecanol from stearic acid. It is often found esterified in waxes.
Synonym: wax alcohol.
(05 Mar 2000)
fatty alcohols Usually high-molecular-weight, straight-chain primary alcohols, but can also range from as few as 4 carbons, derived from natural fats and oils, including lauryl, stearyl, oleyl, and linoleyl alcohols. They are used in pharmaceuticals, cosmetics, detergents, plastics, and lube oils and in textile manufacture.
(12 Dec 1998)
fatty ascites <gastroenterology> A large collection of lymph fluid in the abdominal cavity, sometimes secondary to blockage of the main lymph duct or injury to it.
(27 Sep 1997)
fatty atrophy Fatty infiltration secondary to an atrophy of the essential elements of an organ or tissue.
(05 Mar 2000)
fatty cast A renal or urinary cast consisting largely of fat globules; those containing doubly refractile bodies (composed of cholesterol) are found in the nephrotic syndrome.
(05 Mar 2000)
fatty change The appearance of microscopically visible droplets of fat in the cytoplasm of cells.
See: fatty degeneration.
Synonym: fatty change.
(05 Mar 2000)
fatty cirrhosis Early nutritional cirrhosis, especially in alcoholics, in which the liver is enlarged by fatty change, with mild fibrosis.
(05 Mar 2000)
fatty degeneration Abnormal formation of microscopically visible droplets of fat in the cytoplasm of cells, as a result of injury.
Synonym: adipose degeneration, steatosis.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á